Epiglottitis
Methodology & AI Transparency ⓘ
Epiglottitis Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Epiglottitis—coded clinically as J05.10 across Lungs & Asthma guidelines—combines high-resolution chest imaging in Epiglottitis (J05.10: when indicated) with structured follow-up of Resting Pulse Oximetry in Epiglottitis (J05.10: (SpO2)) (96% – 100% (J05.10)).
- 2 Real-world patient consensus: Diagnostic registry J05.10: Epiglottitis is managed within Lungs & Asthma.
- 3 Typical cash cost range: Differential triage of Epiglottitis (J05.10) utilizes high-resolution chest imaging in Epiglottitis (J05.10: when indicated).
- 4 Top reported side effects / signs: Key Lungs & Asthma biomarkers for Epiglottitis (J05.10): Fractional Exhaled Nitric in Epiglottitis (J05.10: Oxide (FeNO)) & Resting Pulse Oximetry in Epiglottitis (J05.10: (SpO2)) (96% – 100% (J05.10)).
Ask our AI Specialists anything about Epiglottitis
What Is Epiglottitis?
Epiglottitis—coded clinically as J05.10 across Lungs & Asthma guidelines—combines high-resolution chest imaging in Epiglottitis (J05.10: when indicated) with structured follow-up of Resting Pulse Oximetry in Epiglottitis (J05.10: (SpO2)) (96% – 100% (J05.10)).
Pathophysiology, Underlying Causes & Clinical Presentation
Epiglottitis (J05.10) alters lungs & asthma homeostasis through small-airway remodeling [Epiglottitis J05.10]; clinical remission targets Resting Pulse Oximetry in Epiglottitis (J05.10: (SpO2)) within 96% – 100% (J05.10).
Common Symptoms & Clinical Signs
- • Presentation of Epiglottitis (J05.10): chronic productive or in Epiglottitis (J05.10: dry cough worsening)
- • Secondary Epiglottitis clinical sign: prolonged recovery from in Epiglottitis (J05.10: viral respiratory infections)
- • Symptom flares in Epiglottitis correlating with Fractional Exhaled Nitric in Epiglottitis (J05.10: Oxide (FeNO)) deviation outside < 25 ppb (J05.10)
- • Functional lungs & asthma impact requiring high-resolution chest imaging in Epiglottitis (J05.10: when indicated) evaluation (J05.10)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Epiglottitis Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | J05.10 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Asthma, COPD & Respiratory Disease | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Fractional Exhaled Nitric in Epiglottitis (J05.10: Oxide (FeNO)) | < 25 ppb (J05.10) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Resting Pulse Oximetry in Epiglottitis (J05.10: (SpO2)) | 96% – 100% (J05.10) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Blood Eosinophil Count [Epiglottitis J05.10] | < 150 cells/uL (phenotyping marker) (J05.10) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Epiglottitis
Treatment selection for Epiglottitis depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Epiglottitis)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Effect of ensifentrine on dyspnea in patients with moderate-to-severe chronic: What a 975-Participant Study Found Ensifentrine produced clinically meaningful improvements in multiple dyspnea measures in patients with symptomatic, moderate-to-severe COPD. Expert review of respiratory medicine • 2024-08-15 • Phase III Randomized Trial | N = 975 | 93/100 | PMID 39106052 ↗ |
| Can This Approach Help? Inside the Latest Research on Central monitoring in a randomized, open-label, controlled phase 3 clinical trial Central monitoring utilized primary study data in a five-tiered approach, including (1) real-time data checks & topic-specific intervention reports, (2) missing forms reports, (3) quality assurance metrics, (4) critical data... Contemporary clinical trials • 2021-05-15 • Phase III Randomized Trial | Multi-cohort | 82/100 | PMID 33713841 ↗ |
Epiglottitis Patient Community & “People Like Me” Threads
Filter Epiglottitis community threads and patient logs by age, biological sex, dosage, and treatment duration.